pipe, RapiMeds success in the Hong Kong and China market will serve as a springboard to success all across the world. Everything takes time, the word will get out, and other markets will demand this product. And, when other applications for RapiMeds technology are implemented, I go back to what Mr. Schneiderman said, "RapiMeds will surpass compounding's potential." This guy knows what he is doing. All we need to do as investors is be patient and watch it happen.